Discovery of a Novel Oral Glucocorticoid Receptor Modulator (AZD9567) with Improved Side Effect Profile.
Ripa, L., Edman, K., Dearman, M., Edenro, G., Hendrickx, R., Ullah, V., Chang, H.F., Lepisto, M., Chapman, D., Geschwindner, S., Wissler, L., Svanberg, P., Lawitz, K., Malmberg, J., Nikitidis, A., Olsson, R.I., Bird, J., Llinas, A., Hegelund-Myrback, T., Berger, M., Thorne, P., Harrison, R., Kohler, C., Drmota, T.(2018) J Med Chem 61: 1785-1799
- PubMed: 29424542 
- DOI: 10.1021/acs.jmedchem.7b01690
- Primary Citation of Related Structures:  
6EL6, 6EL7, 6EL9 - PubMed Abstract: 
Synthetic glucocorticoids (GC) are essential for the treatment of a broad range of inflammatory diseases. However, their use is limited by target related adverse effects on, e.g., glucose homeostasis and bone metabolism. Starting from a nonsteroidal GR ligand (4) that is a full agonist in reporter gene assays, we exploited key functional triggers within the receptor, generating a range of structurally diverse partial agonists ...